Tweet
Enferm Infecc Microbiol Clin. 2012 Oct;30 Suppl 4:38-42. doi: 10.1016/S0213-005X(12)70103-9.
The impact of influenza A(H1N1)pdm09 infection on immunosuppressed patients.
Cordero E, de la Torre-Cisneros J, Moreno A, P?rez-Romero P, Riera M.
Source
Hospital Universitario Virgen del Roc?o, Instituto de Biomedicina de Sevilla, Sevilla, Spain. Electronic address: mariae.cordero.sspa@juntadeandalucia.es.
Abstract
Before the advent of the influenza A(H1N1)pdm virus in 2009, the information available about the clinical manifestations and prognosis of influenza in immunosuppressed patients was scarce. With the 2009 pandemic, knowledge of the behavior, severity and importance of antiviral therapy for influenza A infection in immunocompromised hosts has increased considerably. The aim of the present manuscript is to review the main challenges of influenza in the most representative immunosuppressed populations such as solid organ transplant recipients, hematopoietic stem cell transplant recipients, patients with solid and hematological cancer and human immunodeficiency virus infected patients.
Copyright ? 2012 Elsevier Espa?a, S.L. All rights reserved.
PMID:
23116791
[PubMed - in process]
The impact of influenza A(H1N1)pdm09 infection on immunosuppressed patients.
Cordero E, de la Torre-Cisneros J, Moreno A, P?rez-Romero P, Riera M.
Source
Hospital Universitario Virgen del Roc?o, Instituto de Biomedicina de Sevilla, Sevilla, Spain. Electronic address: mariae.cordero.sspa@juntadeandalucia.es.
Abstract
Before the advent of the influenza A(H1N1)pdm virus in 2009, the information available about the clinical manifestations and prognosis of influenza in immunosuppressed patients was scarce. With the 2009 pandemic, knowledge of the behavior, severity and importance of antiviral therapy for influenza A infection in immunocompromised hosts has increased considerably. The aim of the present manuscript is to review the main challenges of influenza in the most representative immunosuppressed populations such as solid organ transplant recipients, hematopoietic stem cell transplant recipients, patients with solid and hematological cancer and human immunodeficiency virus infected patients.
Copyright ? 2012 Elsevier Espa?a, S.L. All rights reserved.
PMID:
23116791
[PubMed - in process]
